sábado, 6 de noviembre de 2021

Effect of anti-interleukin drugs in patients with COVID-19 and signs of cytokine release syndrome (COV-AID): a factorial, randomised, controlled trial - The Lancet Respiratory Medicine

Effect of anti-interleukin drugs in patients with COVID-19 and signs of cytokine release syndrome (COV-AID): a factorial, randomised, controlled trial - The Lancet Respiratory Medicine

No hay comentarios:

Publicar un comentario